Related Experiment Video
Updated: Feb 6, 2026

Structure Solution of the Fluorescent Protein Cerulean Using MeshAndCollect
Published on: March 19, 2019
Kineret protein solution survives ten years
1State Key Laboratory for Molecular Biology of Special Economic Animals, Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun, Jilin 130112, China.
Protein biopharmaceuticals typically have short shelf lives. However, this study shows that a human interleukin-1 receptor antagonist (IL-1Ra) solution remained stable for ten years, meeting national security needs for long-term storage.
Area of Science:
- Biopharmaceutical stability
- Protein formulation
- Long-term storage solutions
Background:
- Proteins are inherently unstable in aqueous solutions.
- Typical shelf lives for protein biopharmaceuticals range from months to a few years.
- Extended shelf life is crucial for biopharmaceutical accessibility and national security.
Purpose of the Study:
- To investigate the long-term stability of a protein biopharmaceutical.
- To determine if human interleukin-1 receptor antagonist (IL-1Ra) solution can maintain quality over a decade.
- To assess the potential for meeting national security requirements for extended biopharmaceutical storage.
Main Methods:
- Aqueous solution of human interleukin-1 receptor antagonist (IL-1Ra) was prepared.
- The solution was stored for a period of ten years.
- Quality assessment of the IL-1Ra solution was performed after the ten-year storage period.
Main Results:
- Human interleukin-1 receptor antagonist (IL-1Ra) solution demonstrated remarkable stability.
- The biopharmaceutical solution maintained its quality after ten years of storage.
- This finding challenges the conventional understanding of protein biopharmaceutical shelf life.
Conclusions:
- Protein biopharmaceutical aqueous solutions can potentially be stored for a decade without quality degradation.
- The stability of IL-1Ra offers a viable model for achieving 10-year shelf lives for biopharmaceuticals.
- This breakthrough has significant implications for national security and global health preparedness.
Related Concept Videos
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Comparing the Survival Analysis of Two or More Groups
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Ideal Solutions

